Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-19

Clinical Trial Update: The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated tranexamic acid to reduce blood loss in acetabular surgery, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Acetabular Fractures | Phase 3 | Status: COMPLETED | Results posted: 2021-01-19